Family Health After Predictive Huntington Disease (HD) Testing
Primary Purpose
Huntington Disease
Status
Completed
Phase
Locations
United States
Study Type
Observational
Intervention
Mutation in the gene
Sponsored by
About this trial
This is an observational trial for Huntington Disease focused on measuring Patient Care Management, Family, Huntington's Disease
Eligibility Criteria
Family members of asymptomatic and symptomatic persons with mutation in the gene for Huntington Disease
Sites / Locations
- The University of Iowa College of Nursing
Arms of the Study
Arm 1
Arm Type
Arm Label
1
Arm Description
All Participants hav a family member with Huntington Disease
Outcomes
Primary Outcome Measures
Impact of a positive HD test or presence of HD on a family members perceptions of: health problems, emotional and functional health status, resources/strategies for managing problems, helpfulness, and services needed to help family members cope.
Secondary Outcome Measures
Describe the health care needs, management strategies, and needs for health and social services of a broader sample of relatives/significant others in families in which a person has a gene mutation for HD.
Full Information
NCT ID
NCT00075140
First Posted
January 2, 2004
Last Updated
January 15, 2009
Sponsor
National Institute of Nursing Research (NINR)
1. Study Identification
Unique Protocol Identification Number
NCT00075140
Brief Title
Family Health After Predictive Huntington Disease (HD) Testing
Official Title
Family Health After Predictive Huntington Disease Testing
Study Type
Observational
2. Study Status
Record Verification Date
January 2009
Overall Recruitment Status
Completed
Study Start Date
September 2001 (undefined)
Primary Completion Date
October 2008 (Actual)
Study Completion Date
October 2008 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
National Institute of Nursing Research (NINR)
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to identify health management concerns and needs of family members of asymptomatic and symptomatic persons with mutation in the gene for Huntington Disease (HD).
Detailed Description
This is an observational study with three phases. In Phase 1, focus groups consisting of family members of persons with HD Gene mutation will be conducted and data collected to be analyzed through content analysis to identify salient themes and key issues. In Phase 2, a survey instrument will be developed and field-tested in order to describe the health care needs, management strategies, and needs for health and social services of relative/significant others of asymptomatic and symptomatic persons with the mutation in the gene for HD.
In Phase 3, the survey will be distributed to family members of asymptomatic and symptomatic persons with mutation in the gene for HD and frequencies and comparisons of survey responses according to respondent characteristics will be reported.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Huntington Disease
Keywords
Patient Care Management, Family, Huntington's Disease
7. Study Design
Enrollment
422 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Description
All Participants hav a family member with Huntington Disease
Intervention Type
Genetic
Intervention Name(s)
Mutation in the gene
Primary Outcome Measure Information:
Title
Impact of a positive HD test or presence of HD on a family members perceptions of: health problems, emotional and functional health status, resources/strategies for managing problems, helpfulness, and services needed to help family members cope.
Time Frame
Over 6 yr span
Secondary Outcome Measure Information:
Title
Describe the health care needs, management strategies, and needs for health and social services of a broader sample of relatives/significant others in families in which a person has a gene mutation for HD.
Time Frame
Over 6 yr span
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Family members of asymptomatic and symptomatic persons with mutation in the gene for Huntington Disease
Study Population Description
Family members or significant others, age 14 or older, of persons who 1) have received a positive result from predictive testing for a mutation in the HD gene, 2) are symptomatic and living at home, and 3) are symptomatic and are living in a long-term care institution were the population of interest for this study.
Sampling Method
Probability Sample
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Janet K Williams, PhD, RN, FAAN
Organizational Affiliation
University of Iowa
Official's Role
Principal Investigator
Facility Information:
Facility Name
The University of Iowa College of Nursing
City
Iowa City
State/Province
Iowa
ZIP/Postal Code
52242
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Family Health After Predictive Huntington Disease (HD) Testing
We'll reach out to this number within 24 hrs